Skip to main content
. 2017 Jul 26;14(4):4349–4354. doi: 10.3892/ol.2017.6678

Table II.

IC50 values against docetaxel or gefitinib of docetaxel-resistant cell lines, with or without elacridar treatment.

Docetaxel (nM) Gefitinib (µM)


Elacridar (0.25 µg/ml) + +
H1299DR 272.1 9.4 >10 >10
HCC827DR >1000 21.9 5.0 1.6
HCC4006DR >1000 0.3 8.3 4.7